{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:45:16Z","timestamp":1790937916051,"version":"4.1.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.18410","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T16:21:09Z","timestamp":1627402869000},"page":"e2118410","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma"],"prefix":"10.1001","volume":"4","author":[{"given":"Jifang","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago"},{"name":"School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sweiss","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of Illinois at Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of Illinois at Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi Y.","family":"Ko","sequence":"additional","affiliation":[{"name":"Section of Hematology Oncology, Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritesh R.","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, University of Illinois at Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.-H.","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Calip","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,7,27]]},"reference":[{"issue":"8","key":"zld210147r1","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJM199602223340802","article-title":"Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma.","volume":"334","author":"Berenson","year":"1996","journal-title":"N Engl J Med"},{"issue":"2","key":"zld210147r2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.6004\/jnccn.2017.0023","article-title":"Multiple myeloma, version 3.2017, NCCN clinical practice guidelines in oncology.","volume":"15","author":"Kumar","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"zld210147r3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1200\/JOP.18.00393","article-title":"De-escalation of bone-modifying agents in patients with bone metastases: the best of times and the worst of times?","volume":"14","author":"Awan","year":"2018","journal-title":"J Oncol Pract"},{"issue":"4","key":"zld210147r4","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox's regression model for counting processes: a large sample study.","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Statist"},{"issue":"2","key":"zld210147r5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/biomet\/68.2.373","article-title":"On the regression analysis of multivariate failure time data.","volume":"68","author":"Prentice","year":"1981","journal-title":"Biometrika"},{"issue":"1","key":"zld210147r6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jama.2016.19425","article-title":"Effect of longer-interval vs standard dosing of zoledronic acid on skeletal events in patients with bone metastases: a randomized clinical trial.","volume":"317","author":"Himelstein","year":"2017","journal-title":"JAMA"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2782422\/zhou_2021_ld_210147_1626797342.25396.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T16:21:10Z","timestamp":1627402870000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2782422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,27]]},"references-count":6,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.18410","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,27]]}}}